Press releases
* (R) = Regulatory press releases
Oct 6, 2017
(R) Cantargia obtains patent approval in USA for the antibody CAN04 in development for treatment of cancer
Aug 31, 2017
(R) Cantargia obtains patent approval in Europe for the antibody CAN04 in development for treatment of cancer
Aug 23, 2017
(R) Cantargia publishes half year report
Jul 21, 2017
(R) Cantargia gains approval to initiate the CANFOUR clinical trial of immuno-oncology product candidate CAN04
Jun 26, 2017
(R) Cantargia: Preclinical studies of IL1RAP and CAN04 in solid tumours presented at EACR-AACR-SIC in Florence
Jun 1, 2017
(R) Cantargia obtains patent approval in China for therapy against IL1RAP in acute lymphoblastic leukemia
May 19, 2017
